RE: Todays price22 Sep 2025 11:29
I am, sure FDA approval will be granted, if they get a licensee onboard, but how long ?
They have still yet to start phase III (at a cost to shareholders in lost revenue). Once its completed, there will be a further Q&A period, and then the licensee, will need to sign an agreement with Genetic or a local manufacturer (Remember Keep all things American). This, we know, will take at least a further 18months. Then once all that's done, they need to manufacture the product, then distribute and sell. That will take another 1 to 2 years. So we are looking at probably another 5 years before we see any income stream. So much for the sales and marketing report they spent money on and hyped through announcements 5 years ago. Worth less than the paper it was printed on.
Lest we forget It has been 11 years since they announced an unambiguous way forward with the FDA and "We expect FDA approval by Jun 2017" WTF.
Our only hope is with China, but no one knows when that will be approved, given HK and Macau took double the announced time (in years). If it doesn't come this year, we are all fcuked with yet another low SP dilution leaving us with not much of our investment left in the company. even if there is approval this year, how on earth can they expect sales to start in Jan 2026 ??? Surely the Chinese have not pre-ordered their 100cans (if they can even get that many out of 30k cans/4months). They then need to distribute the cans and start selling . How do they manage that a month after approval - it just doesn't add up.
They have been writing about the DLI for a couple of years now, yet still no income stream. They mention clients, who are they and how much are they paying? If it were anyone of significance, they surely would have mentioned a few names ? Given what was written in the half yearly report, it still looks like the DLI is not contributing much, but IS still costing shareholders to keep it going.
They tout. A supposed billion dollar market for PE, a supposed billion dollar market for the DBC, a supposed billions dollar market for Cannabis and a supposed trillion dollar market for the DLI, yet even after all these years, shareholders have seen nothing but lies and misleading announcements and incompetence that goes with it. That together with total obliteration of shareholder value and loss of investment.
Anything else to add, cos I am sure I have missed something out ?